Drug Shortage Report for MINT-ESCITALOPRAM
Report ID | 100585 |
Drug Identification Number | 02407434 |
Brand name | MINT-ESCITALOPRAM |
Common or Proper name | Escitalopram |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-09 |
Estimated end date | 2020-05-15 |
Actual end date | 2020-06-01 |
Shortage status | Resolved |
Updated date | 2020-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-06-09 | French | Compare |
v6 | 2020-06-09 | English | Compare |
v5 | 2020-04-25 | French | Compare |
v4 | 2020-04-25 | English | Compare |
v3 | 2019-12-10 | English | Compare |
v2 | 2019-12-09 | French | Compare |
v1 | 2019-12-09 | English | Compare |
Showing 1 to 7 of 7